Tag: OTC:CBIIF

November 14, 2019

CB2 Insights to Participate at Piper Jaffray’s 31st Annual Healthcare Conference

CB2 Insights today announced Prad Sekar, CEO of CB2 Insights will be participating in a panel discussion and meeting.
November 8, 2019

CB2 Insights Announces Record Revenue of $4.2 million for the Third Quarter 2019, Sequential Growth of 29 Percent

CB2 Insights (CSE:CBII; OTCQB:CBIIF) announces its results for the three and nine months ended September 30, 2019.
November 1, 2019

CB2 Insights Announces Record Preliminary Unaudited Q3 2019 Revenue of $4.2 Million and Details for Earnings Call

CB2 Insights announced preliminary unaudited revenue of approximately $4.2 million for the three months ended September 30, 2019.
October 29, 2019

VIVO and CB2 Insights Enter Technology and Research Partnership

CB2 Insights Inc. announced it has entered into a technology and multi-phase research agreement with VIVO Cannabis Inc.
October 17, 2019

CB2 Insights CEO: CROs Will Lead the Way in Medical Cannabis

CB2 Insights CEO Prad Sekar joined the Investing News Network to talk about big pharma’s role in medical cannabis and...
October 1, 2019

Why Cannabis Patients Require Accurate Medical Information

The emergence of the medical cannabis industry has created a need for accurate medical data to guide physicians and patients...
September 19, 2019

CB2 Insights Licenses Electronic Data Capture Software to MyAccess Clinics for Use In the UK

CB2 Insights today announced that MyAccess Clinics has selected CB2 Insights’ Electronic Data Capture software to manage patient data in...